GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Tax Expense

Cytophage Technologies (TSXV:CYTO) Tax Expense : C$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Tax Expense?

Cytophage Technologies's tax expense for the months ended in Mar. 2024 was C$0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.00 Mil.


Cytophage Technologies Tax Expense Historical Data

The historical data trend for Cytophage Technologies's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Tax Expense Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
Tax Expense
- - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Tax Expense Get a 7-Day Free Trial - - - - -

Cytophage Technologies Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytophage Technologies  (TSXV:CYTO) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Cytophage Technologies Tax Expense Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytophage Technologies (TSXV:CYTO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies (TSXV:CYTO) Headlines

From GuruFocus